Tokyo, July 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058615) titled 'Exploration of novel biomarker for the eligibility of neoadjuvant chemotherapy followed by operation for the patient with biliary pancreatic cancer' on July 28.
Study Type:
Observational
Primary Sponsor:
Institute - Yamaguchi university Hospital
Condition:
Condition - pancreatic cancer,bile duct cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Multimodal treatment strategies for pancreatic and biliary tract cancers have yet to be fully established. This study aims to comprehensively investigate prognostic factors that influence the resectability and surv...